NCT00192660View on ClinicalTrials.gov

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2007

Conditions
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Interventions
DRUG

Lamivudine

DRUG

Stavudine

DRUG

Didanosine

DRUG

Zidovudine

DRUG

Tenofovir

DRUG

Abacavir

DRUG

Efavirenz (EFV)

DRUG

Nevirapine

DRUG

Indinavir

DRUG

Saquinavir

DRUG

Amprenavir

DRUG

Ritonavir

DRUG

Nelfinavir

DRUG

Tipranavir

DRUG

enfuvirtide (T20)

Trial Locations (1)

2010

St. Vincent's Hospital, Sydney

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
collaborator

St Vincent's Hospital, Sydney

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Kirby Institute

OTHER_GOV